Clinical Trial: Efficacy And Safety Of Azithromycin To Achieve Remissionin In Children With Steroid Sensitive Nephrotic Syndrome

U.S., Jan. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07320612) titled 'Efficacy And Safety Of Azithromycin To Achieve Remissionin In Children With Steroid Sensitive Nephrotic Syndrome' on Nov. 26, 2025.

Brief Summary: To compare efficacy and safety of Azithromycin versus control in children with steroid sensitive nephrotic syndrome

Study Start Date: March 08, 2025

Study Type: INTERVENTIONAL

Condition: Nephrotic Syndrome

Intervention: DRUG: Azithromycin and steroids

80 children will be assigned group A and children will be given Azithromycin along with standard course of steroids.

DRUG: steroids

80 children will be assigned group B and will be given only standard course of treatment

Recruitment...